Most trusted source for Tendering Opportunities and Business Intelligence since 2002
Country - Lithuania
Summary - Antineovascularized Medicines For The Treatment Of Eternal Macular Degeneration (Ranibizumab Or Aflibercept)
Deadline - Apr 22, 2025
GT reference number - 105038774
Product classification - Ophthalmologicals
Address - Lithuania
Contact details - 565656565
Tender notice no. - 76454545
GT Ref Id - 105038774
Document Type - Tender Notices
Description - Description: The Contracting Authority intends to acquire - Antineovascular medicines Ranibizumab and/or aflibecept. Requirements for the subject -matter of the procurement and the amount of medication purchased to determine in the SS Annex 2 "Techni cal Specification".local title:: Antineovaskuliarizuojantys vaistiniai preparatai amžinės geltonosios dėmės degeneracijai gydyti (Ranibizumab arba Aflibercept)Contract Duration: : 12 DAYContract Type: : Supplylocal description: : Perkančioji organizacija numato įsigyti – antineovaskuliarizuojančius vaistinius preparatus Ranibizumab ir/ar Aflibercept. Reikalavimai pirkimo objektui ir perkamas vaistų kiekis nustatyti SS 2 priede „Techni
Gt Ref Id - 105038774
Deadline - Apr 22, 2025
Similar Tenders :
Why Us
3,00,000 +
Users
190 +
Countries Covered
5,00,000 +
Agencies Tracked
50,000 +
Notices Daily
90 Million +
Database